EU MDR Transitional Provisions Officially Extended

The revised provisions provide medical device and in-vitro diagnostics manufacturers with additional time to bring their product into compliance with the new EU Regulations, subject to a number of conditions.

On March 20, 2023, Regulation (EU) no 2023/607 was published in the Official Journal of the European Union, following speedy adoption by the European Parliament and Council. The new Regulation amends Regulation (EU) no 2017/745 (MDR) and Regulation (EU) no 2017/746 (IVDR) and extends the transitional periods set out under these two regulations.

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Latham & Watkins LLP | Attorney Advertising

Written by:

Latham & Watkins LLP
Contact
more
less

Latham & Watkins LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide